Collection-image

TOPICAL COLLECTIONS

Brain Aging: From Insights to Therapeutic Approaches

Submit Abstract

Guest Editor

Liviu Aron

Liviu Aron

Harvard Medical School, Department of Genetics

Dr. Liviu Aron is the Alice Weiner Senior Research Associate in the Paul F. Glenn Center for Biology of Aging Research and the Department of Genetics at Harvard Medical School. Dr. Aron received his MSc in Biochemistry, as well as a Master of Engineering and Engineering Degree in Biotechnology, from the National Institute of Applied Sciences (INSA) of Lyon, France. As an undergraduate and graduate student, he conducted research in neurobiology and genetics during a one-year internship at Karolinska Institute in Stockholm, Sweden, and for his Master’s thesis at INSERM in Lyon, France. Dr. Aron received his PhD from the Max Planck Institute of Neurobiology in Munich, Germany, where he investigated the molecular mechanisms of neurotrophic factor function in the aging brain and Parkinson’s disease, and the involvement of ER stress in retinal degeneration. Since 2010, Dr. Aron has been a postdoctoral and senior research fellow at Harvard Medical School, where he investigates the mechanisms of brain aging, lifespan, and neurodegenerative diseases. Dr. Aron has co-discovered a novel neuroprotective pathway in the aging brain, mediated by the transcriptional repressor REST – and has shown that it regulates systemic aging and lifespan, and acts as a neurodegeneration checkpoint to restrict the development of Alzheimer’s disease. 

Collection Overview

The aging of the brain is accompanied by many alterations that often lead to a decline in neuropsychological abilities, may increase the risk of stroke, and may predispose the elderly to the development of neurodegenerative disorders. Recent evidence suggests, however, that some age-related changes in the brain are beneficial, allowing the brain to compensate for decreased performance and activate stress resistance and resilience pathways. Research over the past two decades has identified robust pathogenic, as well as adaptive neural and glial mechanisms that promote or delay brain and systemic aging. More research is needed to fully characterize these mechanisms and the ways in which they can be optimally engaged or disrupted to preserve function and promote neuroprotection and resilience.

To facilitate this, this collection offers a broad array of experimental approaches to understanding brain aging, as well as therapeutic approaches specifically tailored for the aging brain.

It covers experimental protocols that can be used to gain insight into the mechanisms of brain aging – such as imaging techniques, behavioral assays, in vitro and in vivo models, as well as histologic and molecular assays of brain aging. It also includes experimental protocols for therapeutic intervention in animal models, such as drug delivery, non-invasive protocols that target neural networks (such as gamma entrainment), and interventions that can rejuvenate the aging brain (such as caloric restriction, increased physical exercise, and parabiosis). Taken together, these experimental approaches may stimulate novel discoveries, help improve reproducibility, and stimulate the development of novel therapeutic strategies to prevent, delay, or reverse brain aging.

Articles

Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research
8:20

Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research

0 Views

•

Cited by 5

•

2023

•